March 2026 | Oncology
Ocular Manifestations of Hematological Cancers
Understand the potential ophthalmic involvement of these malignancies.
Adwaita Nag, MBBS, MS, FICO, FMRF, MRCSEd, and Asma Ayub Ansari, MBBS, MS, FRCS Glasgow, MRCSEd, FICO
January/February 2026 | Oncology
Ocular Toxicity From New Oncology Agents
While these drug innovations are exciting, we need to be on alert for a range of ocular complications with this patient population.
Sarah Touhami, MD, PhD
November/December 2025 | Ocular Oncology
Choroidal Metastasis From Lung Adenocarcinoma
Diagnosis of choroidal malignancy should prompt a workup for systemic disease in patients with no known history of cancer.
Weilin Song, MD; Julie K. Kwon, MD; Basil K. Williams Jr, MD; and Jayanth Sridhar, MD
September 2025 | Ocular Oncology
Reducing Chemotherapy Duration for High-Risk Retinoblastoma
Three cycles may offer comparable clinical benefit to six cycles while reducing treatment burden.
Madison M. Woods, BA; Robert J. Medina, BA; and Carol L. Shields, MD
July/August 2025 | Visually Speaking
Features of Choroidal Tuberculoma
Findings on OCT uncovered a rare ocular condition.
Soulaymane Rachda, MD; Yassine Elkhalifa, MD; Selma Ouazzani Touhami, MD; Niima Elfahli, MD; Younes Tlemçani, MD, PhD; Sarah Belghmaidi, MD, PhD; Ibtissam Hajji, MD, PhD; and Abdeljalil Moutaouakil, MD, PhD
July/August 2025 | Ocular Oncology
Surgical Management of Retinal Detachment in Uveal Melanoma
Addressing this complication requires careful planning and follow-up.
Rodrigo Anguita, MBBS, MD, FEBO, FICO, and Lyndon da Cruz, MA, MBBS, PhD, FRCOphth, FRACO
April 2025 | Oncology
The Role of Ultrasonography in Choroidal Melanoma
Tumor shape, readily identified on ultrasound, may have significant prognostic value.
Eugenia M. Ramos-Dávila, MD, and Lauren A. Dalvin, MD
March 2025 | Ocular Oncology
Neoplastic Masqueraders of Uveitis
Remember these various ocular malignancies as you prepare your differential diagnosis.
Ioanna Ploumi, MSc; Konstantina Riri, MD, MSc; and Sofia Androudi, MD, PhD
January/February 2025 | Ocular Oncology
Does Iris Color Matter in Uveal Melanoma?
Research confirms that light eyes are a risk factor.
Charles DeYoung, BA; Alexandra R. Zaloga, BA; Rolika Bansal, MD; and Carol L. Shields, MD
October 2024 | Ocular Oncology
Tissue Glue-Assisted Plaque Radiotherapy for Uveal Melanoma
A potentially safer approach for eyes with a thin sclera.
Robert J. Medina, BA; Madison M. Woods, BA; Rolika Bansal, MD; and Carol L. Shields, MD
September 2024 | Ocular Oncology
Combination Therapy for Metastatic Uveal Melanoma
A look at the response of large choroidal metastatic melanoma to treatment with darovasertib and crizotinib.
Lauren B. Yeager, MD, and Brian P. Marr, MD
July/August 2024 | Ocular Oncology
A Masquerade: Leukemia Retinopathy or Viral Infection?
Ocular symptoms thought to be related to malaria turned out to be signs of systemic malignancy.
Brian Wollocko, MD; Samuel Gelnick, MD; and Eric Shrier, DO, FAAO
July/August 2024 | Fellows' Focus
Lessons From a Case of Primary Intraocular Lymphoma
Here’s how we were able to narrow in on this diagnosis.
Flavius Beca, MD
April 2024 | Ocular Oncology
Ocular Effects of CAR-T Cell Therapy
Know the risks and potential therapeutic benefits associated with this treatment modality.
Lars H. Andersen, MD; Jaskirat S. Takhar, MD; and Jose J. Echegaray, MD
March 2024 | Ocular Oncology
Conditional Survival of Patients With Uveal Melanoma
Factoring in years of metastasis-free survival may lead to an improved prognosis.
Harrison S. Fellheimer, BA; Madison M. Woods, BA; Joseph D. DeSimone, BS; and Carol L. Shields, MD
November/December 2023 | Oncology
The Benefits of Vitrectomy for Uveal Melanoma
The use of vitrectomy techniques is the only way to maximize the best possible vision for patients with uveal melanoma.
Tara A. McCannel, MD, PhD
October 2023 | Ocular Oncology
Choroidal Melanoma: Does Skin Tone Matter?
The literature shows that Fitzpatrick skin type can affect the prognosis and outcomes of cancers.
Irwin Leventer, BA; Kevin R. Card, BS; and Carol L. Shields, MD
September 2023 | Oncology
Cogan-Reese Syndrome: an Iris Melanoma Masquerader
This case highlights the overlap in presentation and distinguishing signs to look for.
Mallory E. Bowers, PhD; Sara E. Lally, MD; and Carol L. Shields, MD
View More Articles